Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974497 | PMC |
| http://dx.doi.org/10.5173/ceju.2013.03.art4 | DOI Listing |
Publication Analysis
Top Keywords
author's reply
4
author's
1
Similar Publications
Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis: Authors' reply.
Pulmonology
December 2025
AP-HP, Pulmonology Department, Avicenne Hospital, Bobigny, France.
Kidney Injury Molecule-1 as a Urinary Biomarker for Aminoglycoside Induced Acute Kidney Injury, among Non-Critically Ill Children: Authors' Reply.
Indian J Pediatr
January 2025
Department of Microbiology, Amala Institute of Medical Sciences, Thrissur, Kerala, 680555, India.
Author's Reply to Liu et al.: "A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal‑Onset Epilepsy".
CNS Drugs
January 2025
Faculty of Medicine, Epilepsy Center, University of Freiburg, Breisacherstr. 64, 79106, Freiburg, Germany.
Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies.
Nat Commun
January 2025
Research Division, Autolus Therapeutics, London, UK.
Extra-articular manifestations in rheumatoid arthritis: Incidence and predisposing factors. Author's reply.
Eur J Intern Med
January 2025
Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!